• linkedin
  • Increase Font
  • Sharebar

    Shock wave therapy found efficacious in treating ED

    Treatment success seen even in non-responders to PDE-5 inhibitors, pooled data show

    Middlebury, CT—Experience with low-intensity extracorporeal shock wave therapy (Li-ESWT) from multinational clinical trials demonstrates it is a safe, effective, and well-tolerated treatment for erectile dysfunction (ED), including in men who do not respond to an oral phosphodiesterase type-5 (PDE-5) inhibitor, reported Robert Feldman, MD, at the AUA annual meeting in New Orleans. 

    Commentary: A curative therapy for ED edges forward

    “Li-ESWT was associated with rapid and robust improvement in objective and subjective efficacy measures that were significantly superior to sham-treated controls. In addition, benefits were achieved among men with all severity levels of ED and were durable through follow-up to 1 year,” said Dr. Feldman, who was one of the investigators and is in private practice in Middlebury, CT.

    “Now, further dose-response studies are planned to define the optimal treatment protocol for select populations.”

    Li-ESWT for ED using the ED1000 Medispec applicator is under review by the FDA. It is currently approved in over 20 countries worldwide. Compared with extracorporeal shockwave lithotripsy, the treatment for ED involves 90% less shock wave bar pressure.

    NEXT: "Quiet, painless, and requires no anesthesia"


    Best of AUA 2015: Sexual Function/Dysfunction

    AUA updates testosterone therapy position statement

    TRT not associated with thrombotic events in older men


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available